A phase I/II trial of trastuzumab plus erlotinib in metastatic HER2-positive breast cancer: a dual ErbB targeted approach
曲妥珠单抗联合厄洛替尼治疗转移性HER2阳性乳腺癌的I/II期临床试验:双重ErbB靶向治疗
期刊:Clinical Breast Cancer
影响因子:2.5
doi:10.3816/CBC.2009.n.003
Britten, Carolyn D; Finn, Richard S; Bosserman, Linda D; Wong, Steven G; Press, Michael F; Malik, Mubashira; Lum, Bert L; Slamon, Dennis J